Skip to main content

Oak Grove Capital LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1661762 Holderness, NH

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$307,132
-$83,104 QoQ
Shares Held
2,431
-13.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,631
of 2,266 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Dec 31, 2021
CallValue
$29,044
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Oak Grove Capital LLC holds $61,174,074 across 4 Drug Manufacturers - General names. GILD ranks #4 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 GILD
Gilead Sciences, Inc.
This page
2,431 $307,132

All Filings in GILD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $307,132 2,431
2026-03-31 $390,236 2,800
2025-12-31 $343,672 2,800
2025-09-30 $310,800 2,800
2025-06-30 $532,176 4,800
2025-03-31 $1,344,600 12,000
2024-12-31 $1,108,440 12,000
2024-09-30 $1,006,080 12,000
2024-06-30 $727,266 10,600
2022-03-31 $380,480 6,400
2021-12-31 $787,818 10,850
2021-12-31 $29,044 400
2021-09-30 $1,023,302 14,650
2021-09-30 $1,000 400
2021-06-30 $2,766,863 40,181
2021-06-30 $1,000 400
2021-03-31 $1,000 400
2021-03-31 $4,999,259 77,352
2020-12-31 $4,599,743 78,952
2020-12-31 $1,000 400
2020-09-30 $4,192,656 66,350
2020-06-30 $2,783,612 36,179
2020-03-31 $7,179,128 96,029